| Computer simulation of liquids MP Allen, DJ Tildesley Oxford university press, 2017 | 45551 | 2017 |
| CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials KF Schulz, DG Altman, D Moher Journal of Pharmacology and pharmacotherapeutics 1 (2), 100-107, 2010 | 23865 | 2010 |
| Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis KM Sjoquist, BH Burmeister, BM Smithers, JR Zalcberg, RJ Simes, ... The lancet oncology 12 (7), 681-692, 2011 | 1951 | 2011 |
| Minimally invasive versus abdominal radical hysterectomy for cervical cancer PT Ramirez, M Frumovitz, R Pareja, A Lopez, M Vieira, R Ribeiro, A Buda, ... New England Journal of Medicine 379 (20), 1895-1904, 2018 | 1789 | 2018 |
| Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised … E Pujade-Lauraine, JA Ledermann, F Selle, V Gebski, RT Penson, ... The lancet oncology 18 (9), 1274-1284, 2017 | 1779 | 2017 |
| Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis V Gebski, B Burmeister, BM Smithers, K Foo, J Zalcberg, J Simes The lancet oncology 8 (3), 226-234, 2007 | 1516 | 2007 |
| Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial ARL Stevenson, MJ Solomon, JW Lumley, P Hewett, AD Clouston, ... Jama 314 (13), 1356-1363, 2015 | 1202 | 2015 |
| Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ... The lancet oncology 6 (9), 659-668, 2005 | 1137 | 2005 |
| Checkpoint inhibitors in metastatic EGFR-mutated non–small cell lung cancer—a meta-analysis CK Lee, J Man, S Lord, M Links, V Gebski, T Mok, JCH Yang Journal of Thoracic Oncology 12 (2), 403-407, 2017 | 813 | 2017 |
| CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration S Hopewell, M Clarke, D Moher, E Wager, P Middleton, DG Altman, ... PLoS medicine 5 (1), e20, 2008 | 770 | 2008 |
| Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse E Pujade-Lauraine, U Wagner, E Aavall-Lundqvist, V Gebski, M Heywood, ... Journal of clinical oncology 28 (20), 3323-3329, 2010 | 721 | 2010 |
| Lymphomas in Eμ-Pim1 transgenic mice exposed to pulsed 900 MHz electromagnetic fields MH Repacholi, A Basten, V Gebski, D Noonan, J Finnie, AW Harris Radiation research 147 (5), 631-640, 1997 | 692 | 1997 |
| Improving the quality of life during chemotherapy for advanced breast cancer A Coates, V Gebski, JF Bishop, PN Jeal, RL Woods, R Snyder, ... New England Journal of Medicine 317 (24), 1490-1495, 1987 | 651 | 1987 |
| Randomised trial of SIR-SpheresŪ plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer B Gray, G Van Hazel, M Hope, M Burton, P Moroz, J Anderson, V Gebski Annals of Oncology 12 (12), 1711-1720, 2001 | 645 | 2001 |
| Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial D Sullivan, AG Olsson, R Scott, JB Kim, A Xue, V Gebski, SM Wasserman, ... Jama 308 (23), 2497-2506, 2012 | 644 | 2012 |
| SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma PKH Chow, M Gandhi, SB Tan, MW Khin, A Khasbazar, J Ong, SP Choo, ... Journal of clinical oncology 36 (19), 1913-1921, 2018 | 643 | 2018 |
| Impact of EGFR inhibitor in non–small cell lung cancer on progression-free and overall survival: a meta-analysis CK Lee, C Brown, RJ Gralla, V Hirsh, S Thongprasert, CM Tsai, EH Tan, ... Journal of the National Cancer Institute 105 (9), 595-605, 2013 | 619 | 2013 |
| Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non–small cell lung carcinoma: a systematic … CK Lee, J Man, S Lord, W Cooper, M Links, V Gebski, RS Herbst, ... JAMA oncology 4 (2), 210-216, 2018 | 540 | 2018 |
| Oxygen saturation and outcomes in preterm infants BOOST II United Kingdom, Australia, and New Zealand Collaborative Groups New England Journal of Medicine 368 (22), 2094-2104, 2013 | 536 | 2013 |
| Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III … NC Tebbutt, K Wilson, VJ Gebski, MM Cummins, D Zannino, ... Journal of clinical oncology 28 (19), 3191-3198, 2010 | 516 | 2010 |
